Integer Holdings is a contract developer and manufacturer of medical device components and finished devices for large OEMs. Its portfolio spans cardiac rhythm management and neuromodulation leads and assemblies, vascular and structural heart products, and other specialized implantable and surgical technologies. Customers rely on Integer for high-reliability manufacturing, design support and scale in regulated markets rather than for branded consumer health products.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 476.5 | — | 37 | — |
| Q3 2025 | 467.7 | — | 39.7 | — |
| Q4 2025 | 472.1 | — | 48.6 | — |
| Q1 2026 | 439.6 | — | 16.5 | — |
| Q2 2026 | 464.1 | -2.6% | 23.6 | -36.2% |
All markets — KeepWinning global stock screener
Other companies on NYSE: First BanCorp. (FBP), Miami International Holdings, Inc. (MIAX), Comstock Resources, Inc. (CRK), Hafnia Limited (HAFN), Travel + Leisure Co. (TNL), Lazard, Inc. (LAZ)